4th Annual International Congress for Regenerative and Cell-Based Medicine
On May 3rd, 2012, the
global cell-medicine community will come together in
Hollywood, Florida for the 4th Annual International Congress for Regenerative
and Cell-Based Medicine.
Lectures will cover a variety of therapeutic areas, from neurological to auto-immune disorders, cell banking, orthopedics, cardiac and wound care and will cover the clinical application of adipose, bone marrow and PRP. There is no other meeting that will be as focused on the point-of-care use of stem cells as this. Join us.
For a full agenda, a
complete list of faculty, and
additional information about the conference, please visit the ICMS website.
Register today, use registration code ICMS, and
join us in Hollywood on May 3rd.
News from the ICMS
Bone Marrow Derived Stem Cells and Multiple
Sclerosis, Saud Ahmed Sadiq, M.D.
Stem Cell Treatment in
Neurological Disease, Augusto Brazzini, M.D.
Platelet Rich Plasma,
Ariel Luksenburg Wiernik, M.D.
Clinical Results from
Autologous Stromal Vascular Fraction (SVF) Treatment of Autoimmune Conditions,
Neil H. Riordan, Ph.D.
Stem Cell Viability and
Different Anesthetics and the Optimization of G-CFS Use, as it Relates to Stem
Cell Induction, Alan A. Kadish, N.M.D.
Stem Cells and
Cardiology, Warren Sherman, M.D.
Emerging Trends in Cell
Banking, Julie Allickson, PhD
From Bench to Bedside:
Clinical Translation of Innovative Therapies - Panel Discussion, Todd
McAllister, PhD., Francesca Vitelli, PhD. and Warren Sherman, MD
Adipose Derived Stem
Cells in Degenerative Diseases, Kristin Comella
The Role of Platelet
Rich Plasma in Adjuvant Wound Care - Clinical Experience Case Series, Ravi K.
Stem Cells and
Orthopedic Conditions, Christopher Centeno, M.D.
Latest Research - Adipose
Mesenchymal Stem Cells (MSC) are
arising as a potent therapeutic tool in transplantation due to their
regenerative and immunomodulatory properties. The research on MSCs has mainly
focused on their effects on T cells and although data regarding the modulatory
effects of MSCs on alloantigen-specific humoral response in humans is scarce,
it has been demonstrated that MSCs significantly affect B cell functioning.
Endogenous progenitor cell mobilization enhances LD fat
neovascularization, increases vasculogenic cytokine expression, and
improves graft survival to a level equal to HD fat grafts.
Examination and comparison ofimmunomodulatory function
of CP-MSCs with that of BM-MSCs and AD-MSCs using co-culture system with
activated T-cells derived from human umbilical cord blood (UCB) suggest that
while CP-MSCs, BM-MSCs, and AD-MSCs all have immunomodulatory effects, CP-MSCs
may have additional advantage over the other MSCs in terms of immunomodulation.
In conjunction with other previous studies, CP-MSCs are suggested to be a
useful stem cell source in cell therapy.
Study to investigate the effect of long-term culture
on the adipogenic, stemness and osteogenic genes expression during osteogenic
induction of ASCs. In this study, the molecular characteristics of ASCs during
osteogenic induction in long-term culture was analysed by observing their
morphological changes during induction, analysis of cell mineralization using
Alizarin Red staining and gene expression changes using quantitative RT-PCR.
Study on the effective expansion of human
adipose-derived stromal cells and bone marrow-derived mesenchymal stem cells
cultured on a fragmin/protamine nanoparticles-coated substratum with human
ASC-enriched lipofilling theoretically has the potential for
transforming lipofilling from a relatively unpredictable
intervention into one in which the resorption rate, quality of tissue, and
safety can be predicted, and possibly superior to prosthetic implantation.
in Cell Medicine is a monthly publication from the ICMS.
To comment on
articles, or suggest items for this newsletter, please contact the ICMS at firstname.lastname@example.org
Please join Med Pro at the ICMS member reception immediately
following the 4th Annual Congress to hear a special talk on Healthcare &
Medical Tourism Marketing by internationally recognized marketing expert
Patrick Goodness, CEO of the Goodness Company. The talk will center on the importance
of social media, public relations, website marketing, video marketing and
more. Additionally, Patrick will discuss information on the
importance of marketing in compliance with FTC regulations.
This special lecture, sponsored by Med Pro, will be open to all attendees of
the ICMS Conference. Please join us at 6:30 PM on Thursday, May 3rd.
Latest Stem Cell Research